Article
Methylation of the RARB gene increases prostate cancer risk in black Americans.
The Journal of urology - 1 Jul 2013
Tang Deliang, Kryvenko Oleksandr N, Mitrache Nicoleta, Do Kieu C, Jankowski Michelle, Chitale Dhananjay A, Trudeau Sheri, Rundle Andrew, Belinsky Steven A, Rybicki Benjamin A
Abstract excerpt
PURPOSE: Gene promoter hypermethylation may be useful as a biomarker for cancer risk in histopathologically benign prostate specimens. MATERIALS AND METHODS: We performed a nested case-control study of gene promoter methylation status for 5 genes (APC, RARB, CCND2, RASSF1 and MGMT) measured in benign biopsy specimens from 511 prostate cancer case-control pairs. We estimated the overall and race stratified risk of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
